Figure 4From: Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trialMarkers of muscle damage and inflammation. A. Creatine kinase (CK), B. high-sensitivity CRP (hsCRP), C. interleukin-8 (IL-8) and D. monocyte chemoattractant protein-1 (MCP-1) levels measured at baseline and 2 and 24 hours after the downhill running test. *p < 0.05.Back to article page